CSIS Issues Commentary: Securing the Future of the U.S. Biopharmaceutical Industry - The Most-Favored-Nation Paradox
January 14, 2026
January 14, 2026
WASHINGTON, Jan. 14 -- The Center for Strategic and International Studies issued the following commentary on Jan. 13, 2026:
* * *
Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox
By Sujai Shivakumar and Anne Pritchett
The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as "global freeloading" and to ensure U.S. patients pay prices comparabl . . .
* * *
Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox
By Sujai Shivakumar and Anne Pritchett
The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as "global freeloading" and to ensure U.S. patients pay prices comparabl . . .